0Studies tracked
0Claims cite
0Videos use
Average study score: 72/100
Bibliography
Studies by this author
1 study attributed to Vincent Wai‐Sun Wong on the platform. Click a card to read the full analysis.
Study
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2-F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study.
The study evaluated the efficacy and safety of ervogastat (DGAT2 inhibitor) alone and in combination with clesacostat (ACC inhibitor) in adults with biopsy-confirmed MASH and fibrosis stages F2-F3.